Related Experiment Video
Updated: Aug 15, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease
1Department of Medicine, University of Washington, Seattle, WA 98195-6426, USA. joram@u.washington.edu
Insights
The ATP-binding cassette transporter A1 (ABCA1) pathway is crucial for cholesterol removal and cardiovascular health. Impaired ABCA1 function contributes to atherosclerosis, particularly in metabolic disorders, highlighting its therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Science
Background:
- High-density lipoprotein (HDL) levels correlate inversely with cardiovascular disease risk.
- ATP-binding cassette transporter A1 (ABCA1) facilitates cholesterol and phospholipid transport to HDL, playing a key role in HDL metabolism.
- ABCA1 is vital for initiating HDL particle formation in the liver and protecting arteries from atherosclerosis in macrophages.
Purpose of the Study:
- To explore the role of the ABCA1 pathway in cardiovascular disease and its potential as a therapeutic target.
- To investigate how metabolic syndrome and diabetes affect ABCA1 function and cholesterol export.
- To examine the impact of oxidative modifications on HDL and ABCA1-mediated cholesterol removal.
Main Methods:
- Review of existing literature on ABCA1 function, genetics, and its role in HDL metabolism and atherogenesis.
- Analysis of studies involving genetic manipulation of ABCA1 in animal models.
- Examination of the effects of metabolites associated with metabolic syndrome and diabetes on ABCA1 stability and activity.
Main Results:
- ABCA1 mutations lead to severe HDL deficiency, cholesterol deposition, and atherosclerosis.
- Genetic alterations in ABCA1 expression influence plasma HDL levels and atherogenesis in mice.
- Metabolic syndrome and diabetes-associated metabolites destabilize ABCA1, reducing macrophage cholesterol export.
- Oxidative modifications of HDL impair ABCA1-mediated cholesterol removal in cardiovascular disease patients.
Conclusions:
- An impaired ABCA1 pathway likely contributes to increased atherosclerosis in inflammatory and metabolic disorders.
- The ABCA1 pathway represents a significant therapeutic target for cardiovascular disease treatment.
Abstract:
Blood high-density lipoprotein (HDL) levels are inversely related to risk for cardiovascular disease, implying that factors associated with HDL metabolism are atheroprotective. One of these factors is ATP-binding cassette transporter A1 (ABCA1), a cell membrane protein that mediates the transport of cholesterol, phospholipids, and other metabolites from cells to lipid-depleted HDL apolipoproteins. ABCA1 transcription is highly induced by sterols, a major substrate for cellular export, and its expression and activity are regulated posttranscriptionally by diverse processes. Liver ABCA1 initiates formation of HDL particles, and macrophage ABCA1 protects arteries from developing atherosclerotic lesions. ABCA1 mutations can cause a severe HDL deficiency syndrome characterized by cholesterol deposition in tissue macrophages and prevalent atherosclerosis. Genetic manipulations of ABCA1 expression in mice also affect plasma HDL levels and atherogenesis. Metabolites elevated in individuals with the metabolic syndrome and diabetes destabilize ABCA1 protein and decrease cholesterol export from macrophages. Moreover, oxidative modifications of HDL found in patients with cardiovascular disease reduce the ability of apolipoproteins to remove cellular cholesterol by the ABCA1 pathway. These observations raise the possibility that an impaired ABCA1 pathway contributes to the enhanced atherogenesis associated with common inflammatory and metabolic disorders. The ABCA1 pathway has therefore become an important new therapeutic target for treating cardiovascular disease.
Related Concept Videos
The ADP/ATP Carrier Protein
ABC Transporters: Exporter
Cholesterol: Significance and Regulation
Considering cholesterol and...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

